Spero Therapeutics, Inc. (SPRO) News & Overview - Discounting Cash Flows
SPRO
Spero Therapeutics, Inc.
SPRO (NASDAQ)

SPRO's Business Model

Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adults; SPR206, a direct acting IV-administered agent to treat MDR Gram-negative bacterial infections in the hospital; and SPR720, an oral antibiotic for the treatment of non-tuberculous mycobacterial pulmonary disease. It has license agreement with Meiji Seika Pharma Co., Ltd. to support the development of tebipenem HBr; license agreement with Everest Medicines to develop, manufacture, and commercialize SPR206 in Greater China, South Korea, and Southeast Asian countries; collaboration agreement with Bill & Melinda Gates Medical Research Institute to develop SPR720 for the treatment of lung infections caused by Mycobacterium tuberculosis; and license agreement with Vertex Pharmaceuticals Incorporated for patents relating to SPR720, as well as SPR719, an active metabolite. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.
Sector & Industry Healthcare / Biotechnology
Website https://sperotherapeutics.com
CEO (Chief Executive Officer) Esther P. Rajavelu
Number of Employees
IPO date November 2, 2017

SPRO Latest News

Contact
CountryUS
Address675 Massachusetts Avenue
CityCambridge
StateMA
Phone857 242 1600
Zip Code02139
Other Identifiers
CIK0001701108
ISINUS84833T1034
CUSIP84833T103
Open2.9
Previous Close2.9
Volume390.1 Thou.
Average Volume4.32 Mil.
Day’s Range2.9 – 2.94
52 Week Range0.505-3.09
MA (50)1.75918
MA (200)1.19577
Market Cap162.7 Mil.
Shares Out.55.91 Mil.
Earnings DateAug 04, 2025
Beta
Last Dividend
EPS
PE

Industry Competitors for SPRO

discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us